FibroGen Financial Overview
FibroGen's market cap is currently $35.03M. The company's EPS TTM is $49.61; its P/E ratio is 0.21; FibroGen is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-3.88. See an overview of income statement, balance sheet, and cash flow financials.
